Skip to main content
. Author manuscript; available in PMC: 2016 Sep 20.
Published in final edited form as: Int J Mycobacteriol. 2014 Mar 24;3(2):132–138. doi: 10.1016/j.ijmyco.2014.02.004

Table 4.

Analyses of risk factors for pulmonary TB among study participants (n = 250), Gondar University Hospital, Northwest Ethiopia, 2012.

Characteristic Univariate analysis
Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Age (year) 1.02 (0.96–1.08) 0.60
Female 1.58 (0.41–6.20) 0.51
Married 0.27 (0.06–1.25) 0.09 0.31 (0.06–1.52) 0.15
Unemployed 0.69 (0.20–2.31) 0.54
Illiterate 0.57 (0.15–2.20) 0.41
Any alcohol use 1.75 (0.36–8.50) 0.49
Previous contact with TB 1.17 (0.14–9.51) 0.89
Household members >4 1.58 (0.47–5.34) 0.46
HIV
WHO stage III/IV vs. I/II 1.12 (0.32–3.92) 0.87
HAART use 0.58 (0.17–1.96) 0.38
CD4+ T cell count <200 2.93 (0.86–9.96) 0.09 2.54 (0.68–9.56) 0.17
History of TB treatment 1.41 (0.40–4.96) 0.59
Current OIs
 Thrush 0.56 (0.07–4.54) 0.59
 Pneumonia 3.89 (0.96–15.79) 0.06 4.81 (1.08–21.43) * 0.04 *
 Herpes Zoster 0.66 (0.24–3.15) 0.61
Symptoms
 Fever 0.83 (0.24–2.93) 0.77
 Cough 2.31 (0.49–10.92) 0.29
 Weight loss 2.62 (0.78–8.87) 0.12 2.38 (0.67–8.43) 0.10
 Night sweats 1.76 (0.46–6.80) 0.41
CXR infiltrate 0.58 (0.07–4.84) 0.61

TB – tuberculosis; OR – odds ratio; CI – confidence interval; HAART – highly active antiretroviral therapy; CD – cluster of differentiation; OIs – opportunistic infections; CXR – chest X-ray.

*

Statistically significant.